Intravacc B.V.
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Private
- Established
- 2012-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.intravacc.nl
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers
Phase 1
Completed
- Conditions
- COVID-19
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Intravacc B.V.
- Target Recruit Count
- 40
- Registration Number
- NCT05604690
- Locations
- 🇦🇺
University of the Sunshine Coast Clinical Trial Centre, Sippy Downs, Queensland, Australia
News
No news found